MSL positions were created in the late 60’s to inform and influence Key Opinion Leaders (KOLs) in the medical field through relationships and research collaborations. Over time, the role of the MSL has evolved and now almost all MSLs serve as vital resources for pharmaceutical and biotech firms in regards to staying on top of [...]
A new hybrid KOL engagement model is taking hold. Although the effects of the pandemic are still being felt to various degree of magnitude throughout the world, there is a sense of normalcy looming on the horizon. Now that the rate of full vaccination is gradually rising and protection restrictions are dropping, Medical Science Liaisons [...]
"Key Metrics for MSLs: 10 Essentials for Medical Science Liaisons" presents our findings to help MSLs get a head start on some important aspects of the role. For years, we have been researching the medical science liaison function and operations, and thought leader management best practices. We put together this document that outlines some of [...]
The Medical Science Liaison job has been growing over the past 30 years, at first being mostly developed and refined in North America and gradually taking hold in other parts of the world, as companies gradually implemented Medical Affairs function throughout their organization. Like any other career, a Medical Science Liaison job is not immune [...]
Medical Affairs Key Considerations in Post COVID-19 Era presents results of the impact of the global shutdown on MSL teams. It also provides key take-aways to address and outlines a few challenging hurdles to overcome in the near future. Arx Research conducted a brief survey to assess how the COVID pandemic reshaped the Medical Science [...]
A successful Medical Affairs launch strategy requires every part of an organization to work in sync. For Medical Affairs, it means that by the time a product “hits” the market, most of the function will be staffed. It also means the medical field team programs will have gradually matured into a fully operational structure. Thought [...]
The Altered Pharmaceutical Thought Leader Pool: How the Implementation of the Sunshine Act and CMS Open Payment Program Changed the KOL Landscape Since the adoption of the Sunshine Act in 2010 and the subsequent thought leaders’ payments reporting on the CMS Open Payment Program in 2014, many things have changed for pharmaceutical companies. It took [...]
There’s a category of thought leader that has long been overlooked, but the data now suggests companies can no longer afford to do so—that category is the Non-MD category of Nurse Practitioners (NP) and Physician Assistants (PA). From our contacts in continuing medical education (CME), we’ve heard there has been a marked increase in the [...]
Research shows what European KOLs think of MSLs they interact with. Through the deployment of scientific field teams (MSLs), organizations’ intentions are to share medical and clinical knowledge of products with the thought leaders who in turn can spread the information to physician communities and ultimately enhance patient experiences. In the process, thought leaders become [...]
A new research study MSL Performance Metrics: Valuing the Role Throughout a Product's Lifecycle reveals key indicators on MSL performance reviews and identify the most common trends and perceptions among the medical affairs executives including how they see the 3 phases of MSL Performance Reviews. The full study presents an assessment of current practices, feedback from 37 [...]
